21 results
8-K
EX-1.1
ACXP
Acurx Pharmaceuticals, Inc.
15 Nov 23
Entry into a Material Definitive Agreement
5:02pm
or toxic substances or waste and protection of health and safety or the environment which are applicable to their businesses (“Environmental Laws”), except
8-K
EX-10.1
opa4algwgpwr
17 May 23
Acurx Pharmaceuticals, Inc. Announces Pricing of $4.0 Million Registered Direct Offering
4:19pm
8-K
EX-10.1
nzq0fzdqdpfm6h57jpvc
25 Jul 22
Acurx Pharmaceuticals, Inc. Announces $4.225 Million Registered Direct Offering
8:46am
10-K
e9pqwedr
16 Mar 22
Annual report
4:05pm
10-Q
zqc oyph0ou5
13 Aug 21
Quarterly report
4:06pm
424B4
25yoi 745e
28 Jun 21
Prospectus supplement with pricing info
6:02am
S-1/A
qotjzi
11 Jun 21
IPO registration (amended)
6:02am
S-1
qja mf7xx
27 May 21
IPO registration
12:00am
DRS/A
3yiuiqdeh0yhkj4eqg
10 May 21
Draft registration statement (amended)
12:00am